A notice from a drug dealer: Difficulties in purchasing a 4+7 variety

Are these medicines out of stock?

1.

The announcement showed that two varieties of calcium carbonate tablets and dexmedetomidine hydrochloride injection had difficulties in purchasing.

According to the company's official website, Zhejiang Jinyi Pharmaceutical Co.

Judging from this information, the company's announcement of difficult-to-purchase products may involve hospital channels or retail channels.

2.

Speaking of dexmedetomidine hydrochloride injection, there is a lot of attention in the 4+7 volume purchase.

In the 4+7 contract extension, dexmedetomidine hydrochloride injection once again became the focus of discussion in the industry.

According to industry analysis, in the renewal phase of the national centralized procurement, the competition for some varieties is still very fierce.

As for the above announcement, why dexmedetomidine hydrochloride injection has become a difficult product to purchase, the real reason is not yet known.

For each batch of national procurement, the follow-up will face the problem of contract renewal.

At present, in addition to advancing the fifth batch of national procurement, the renewal of the previous batches is a top priority.

The industry believes that these national procurement renewals will bring market opportunities for newly reviewed companies, but the entire market may also usher in greater changes.